BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 10805756)

  • 21. Transcription factor GATA-4 is activated by phosphorylation of serine 261 via the cAMP/protein kinase a signaling pathway in gonadal cells.
    Tremblay JJ; Viger RS
    J Biol Chem; 2003 Jun; 278(24):22128-35. PubMed ID: 12670947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors.
    Stokes DG; Liu G; Dharmavaram R; Hawkins D; Piera-Velazquez S; Jimenez SA
    Biochem J; 2001 Dec; 360(Pt 2):461-70. PubMed ID: 11716775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyclic adenosine 3',5'-monophosphate and protein kinase A on ligand-dependent transactivation via the vitamin D receptor.
    Nakajima S; Yamagata M; Sakai N; Ozono K
    Mol Cell Endocrinol; 2000 Jan; 159(1-2):45-51. PubMed ID: 10687851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tissue-specific transcription factor LFB3 in a cyclic AMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 cells.
    Soubt MK; Marksitzer R; Menoud PA; Nagamine Y
    Mol Cell Biol; 1998 Aug; 18(8):4698-706. PubMed ID: 9671480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.
    Sette C; Conti M
    J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serine 27, a human retinoid X receptor alpha residue, phosphorylated by protein kinase A is essential for cyclicAMP-mediated downregulation of RXRalpha function.
    Harish S; Ashok MS; Khanam T; Rangarajan PN
    Biochem Biophys Res Commun; 2000 Dec; 279(3):853-7. PubMed ID: 11162439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.
    Han Y; Lefebvre V
    Mol Cell Biol; 2008 Aug; 28(16):4999-5013. PubMed ID: 18559420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene.
    Liu Y; Li H; Tanaka K; Tsumaki N; Yamada Y
    J Biol Chem; 2000 Apr; 275(17):12712-8. PubMed ID: 10777565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
    Sakamoto Y; Yoshida M; Semba K; Hunter T
    Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
    Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
    Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9.
    Xie WF; Zhang X; Sakano S; Lefebvre V; Sandell LJ
    J Bone Miner Res; 1999 May; 14(5):757-63. PubMed ID: 10320524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway.
    Lefebvre V; Behringer RR; de Crombrugghe B
    Osteoarthritis Cartilage; 2001; 9 Suppl A():S69-75. PubMed ID: 11680692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone enhances SOX9 expression in chondrocytes.
    Sekiya I; Koopman P; Tsuji K; Mertin S; Harley V; Yamada Y; Shinomiya K; Nifuji A; Noda M
    J Endocrinol; 2001 Jun; 169(3):573-9. PubMed ID: 11375127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9.
    Tsuda M; Takahashi S; Takahashi Y; Asahara H
    J Biol Chem; 2003 Jul; 278(29):27224-9. PubMed ID: 12732631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new long form of c-Maf cooperates with Sox9 to activate the type II collagen gene.
    Huang W; Lu N; Eberspaecher H; De Crombrugghe B
    J Biol Chem; 2002 Dec; 277(52):50668-75. PubMed ID: 12381733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes.
    Aigner T; Gebhard PM; Schmid E; Bau B; Harley V; Pöschl E
    Matrix Biol; 2003 Jun; 22(4):363-72. PubMed ID: 12935820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ihh enhances differentiation of CFK-2 chondrocytic cells and antagonizes PTHrP-mediated activation of PKA.
    Deckelbaum RA; Chan G; Miao D; Goltzman D; Karaplis AC
    J Cell Sci; 2002 Jul; 115(Pt 14):3015-25. PubMed ID: 12082161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional suppression of Sox9 expression in chondrocytes by retinoic acid.
    Sekiya I; Koopman P; Tsuji K; Mertin S; Harley V; Yamada Y; Shinomiya K; Niguji A; Noda M
    J Cell Biochem Suppl; 2001; Suppl 36():71-8. PubMed ID: 11455572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid transcription factor 1 phosphorylation is not required for protein kinase A-dependent transcription of the thyroglobulin promoter.
    Feliciello A; Allevato G; Musti AM; De Brasi D; Gallo A; Avvedimento VE; Gottesman ME
    Cell Growth Differ; 2000 Dec; 11(12):649-54. PubMed ID: 11149600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.